← Back to Search

Behavioral Intervention

COVID-19 Prevention Program for Coronavirus

N/A
Waitlist Available
Led By Maria E Fernandez-Esquer, PhD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks post intervention
Awards & highlights

Study Summary

This trial looks at how well people follow COVID safety guidelines after getting advice from doctors.

Who is the study for?
This trial is for Hispanic or Latino individuals who are seeking work at designated street corners. Participants must not have been hired from a corner before and should not have had COVID-19 symptoms in the past 48 hours.Check my eligibility
What is being tested?
The study aims to see if a program designed for Latino Day Laborers helps them follow practices that prevent COVID-19 better than just standard advice. It includes group problem-solving sessions and an additional booster session.See study design
What are the potential side effects?
Since this trial focuses on behavior change rather than medication, there aren't direct side effects like with drugs. However, participants may experience stress or discomfort during discussions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks post intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks post intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in COVID-19 Vaccination Status assessed by a survey
Change in Mask Wearing frequency as assessed by a survey
Percentage of participants who reported contacting the agency for assistance to get food
+2 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Group Problem Solving Plus Booster SessionExperimental Treatment3 Interventions
Group II: COVID-19 Group Problem SolvingExperimental Treatment2 Interventions
Group III: Standard of CareActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
COVID-19 Group Problem Solving
2023
N/A
~560
Standard of Care
2017
Completed Phase 4
~4420
Booster session
2023
N/A
~2360

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center, HoustonLead Sponsor
903 Previous Clinical Trials
320,618 Total Patients Enrolled
National Institute on Minority Health and Health Disparities (NIMHD)NIH
381 Previous Clinical Trials
1,215,697 Total Patients Enrolled
Maria E Fernandez-Esquer, PhDPrincipal InvestigatorThe University of Texas Health Science Center, Houston
1 Previous Clinical Trials
200 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants have joined this research endeavor thus far?

"Affirmative. Clinicaltrials.gov displays that this clinical trial, initially posted on November 3rd 2023, is currently enrolling participants. There is an urgent need for 360 patients at one particular location."

Answered by AI

Are there any spaces available to join this trial as a participant?

"Yes, the data on clinicaltrials.gov affirms that this research is actively engaging in recruitment efforts. The trial was inaugurated on November 3rd 2023 and last updated two weeks later; it seeks to enrol 360 participants from a single medical facility."

Answered by AI

Who else is applying?

What site did they apply to?
The University of Texas Health Science Center at Houston
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
Vale+Tú Salud: Corner-Based Randomized Trial to Test a Latino Day Laborer Program Adapted to Prevent COVID-19
Maria Eugenia Fernandez-Esquer 2023. "Vale+Tú Salud: Corner-Based Randomized Trial to Test a Latino Day Laborer Program Adapted to Prevent COVID-19". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06146361.
~239 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top